Synthesized OVA<sub>323-339</sub>MAP octamers mitigate OVA-induced airway inflammation by regulating Foxp3 T regulatory cells
<p>Abstract</p> <p>Background</p> <p>Antigen-specific immunotherapy (SIT) has been widely practiced in treating allergic diseases such as asthma. However, this therapy may induce a series of allergic adverse events during treatment. Peptide immunotherapy (PIT) was explo...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2012-07-01
|
| Series: | BMC Immunology |
| Subjects: | |
| Online Access: | http://www.biomedcentral.com/1471-2172/13/34 |